Pricing

CORMORANT ASSET MANAGEMENT, LP

3 followers ยท
BOSTON MA Investment Advisor Hedge Fund
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Cormorant Asset Management is based out of Boston. Cormorant Asset Management is a hedge fund with 12 clients and discretionary assets under management (AUM) of $3,117,053,633 (Form ADV from 2023-11-13). Their last reported 13F filing for Q4 2023 included $2,093,868,226 in managed 13F securities and a top 10 holdings concentration of 62.79%. Cormorant Asset Management's largest holding is MoonLake Immunotherapeutics with shares held of 8,494,151. Whalewisdom has at least 42 13F filings, 4 13D filings, 229 13G filings, and 74 Form 4 filings

2023-12-31

Top Buys (13F)

2023-12-31

Top Sells (13F)

2023-12-31

13F Holdings Summary

Name $ Change
MLTX MoonLake Immunothera 24.5%
AMAM Ambrx Biopharma Inc. 7.64%
EYPT EYEPOINT PHARMACEUTI 6.66%
BBIO BridgeBio Pharma Inc 6.45%
ACLX Arcellx Inc 4.51%

2023-12-31

13F Activity

Market Value $2.09b, Prior: $1.71b
New Purchases 9 stocks
Added To 12 stocks
Sold out of 10 stocks
Reduced holdings in 13 stocks
Top 10 Holdings % 62.79%
Turnover %[1] 39.58%
Turnover Alt %[2] 18.3%
Time Held Top 20 2.55 quarters
Time Held Top 10 2 quarters
Time Held All 7.31 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2023-12-31

13F Sector Allocation Over Time

2023-12-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31

Portfolio Performance